Vbi Vaccines, Inc. (NASDAQ:VBIV)

CAPS Rating: 1 out of 5

A holding company whose operating subsidiary, Paulson Investment Company, Inc., is a service brokerage firm engaged in the financial services industry.

VBIV News and Commentary


How do you think VBIV will perform against the market?

Add Stock to CAPS Watchlist

All Players

8 Outperform
32 Underperform

All-Star Players

2 Outperform
29 Underperform

Wall Street

0 Outperform
0 Underperform

Top VBIV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

SmartAce (99.97)
Submitted January 19, 2016

-Why don’t you ever see hippopotamus hiding in trees? -Because they’re really good at it.


Fools bearish on VBIV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VBIV.


Member Avatar OklaBoston (58.03) Submitted: 4/14/2018 4:24:23 PM : Outperform Start Price: $3.41 VBIV Score: -12.49

Insider open market buying since the last insider open market sale.


Member Avatar LookMomBoogers (91.18) Submitted: 3/15/2018 11:11:55 AM : Outperform Start Price: $3.87 VBIV Score: -19.89

Call it hope for me, I was diagnosed with Glioblastoma this past December, they're working on an immunotherapy cure for a terminal brain cancer. I hope they get it and I'm buying some shares and my Dr team might be reaching out after my rounds of Chemo and radiation to see if they need a relatively young and healthy patient for an additional subject in their trials. Let's hope it works, because it's generally a pretty devastating diagnosis but, I'm an optimist and I want to be one of the ones that beats this bastard!


Member Avatar SaintCroix (99.03) Submitted: 2/13/2018 9:24:07 PM : Outperform Start Price: $3.69 VBIV Score: -20.31

I'm fascinated by Phillip Frost, the biotech billionaire who loves to invest in micro-cap stocks. He and his team have a history of using reverse-mergers to introduce start-ups into the public markets. Presumably they want to avoid all the regulatory crap that goes along with an IPO. Not to mention banks taking a good chunk of your equity. I feel like Frost is one of the good guys. And this company, focused on a Hepatitis B vaccine, just might beat the pants off Glaxo. (The CEO is a former Glaxo guy).



Find the members with the highest scoring picks in VBIV.

Score Leader


whatsthepoint (99.97) Score: +130.97

The Score Leader is the player with the highest score across all their picks in VBIV.

Member Name Member
Call Time
Score Commentary
benedict23 85.39 6/8/2016 Underperform 5Y $4.35 -29.89% +28.47% +58.35 0 Comment
TinyCapsWatch 99.90 8/1/2016 Underperform 5Y $3.85 -20.78% +25.31% +46.08 0 Comment
80brown 99.96 7/29/2016 Underperform 5Y $3.78 -19.31% +25.80% +45.11 0 Comment
panda91 74.95 7/22/2016 Underperform 1Y $3.73 -18.23% +25.67% +43.90 0 Comment
DrDoofenshmirtz 99.41 5/4/2017 Underperform 5Y $4.30 -29.07% +14.08% +43.15 0 Comment
Reallynow222 97.16 2/6/2017 Underperform 5Y $3.89 -21.59% +18.86% +40.45 0 Comment
dinasourneil < 20 8/19/2016 Underperform 5Y $3.60 -15.28% +24.66% +39.94 0 Comment
foolishfun4me 99.58 12/9/2016 Underperform 5Y $3.57 -14.57% +20.58% +35.14 0 Comment
antigrowth 96.91 1/2/2018 Underperform 5Y $4.28 -28.74% +1.61% +30.35 0 Comment
OttoLutz 97.79 11/1/2016 Underperform 5Y $3.03 +0.66% +27.81% +27.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VBIV.

Featured Broker Partners